ArticleBreast cancer research : BCR2021

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models.

Seyed Pairawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.